Zacks Research Brokers Raise Earnings Estimates for Exelixis
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Stock analysts at Zacks Research boosted their Q2 2025 EPS estimates for shares of Exelixis in a note issued to investors on Monday, March 3rd. Zacks Research analyst E. Bagri now expects that the biotechnology company will earn $0.47 per share for the quarter, up from their prior […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Stock analysts at Zacks Research boosted their Q2 2025 EPS estimates for shares of Exelixis in a note issued to investors on Monday, March 3rd. Zacks Research analyst E. Bagri now expects that the biotechnology company will earn $0.47 per share for the quarter, up from their prior […]
